David Sveen Added to Heska's Board of Directors New Director to Join Board's Compensation and Corporate Governance Committees
LOVELAND, Colo., Dec. 2, 2013 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading provider of veterinary diagnostic and specialty products, announced today that David Sveen, Ph.D. had joined Heska's Board of Directors.
Dr. Sveen is the President of Cedarstone Partners, Inc., an accounting and consulting practice for nonprofit organizations, which he founded in 1993. Dr. Sveen has also been an adjunct assistant professorship of Christian Formation and Ministry at Wheaton College since 1995. His professional background includes 13 years in senior management with the investment banking firm Griffin, Kubik, Stephens and Thompson.
Dr. Sveen earned his BS in Business from Northern Illinois University in 1978 and his MBA from DePaul University in 1986. In 1994 he earned his MA in Educational Ministries from Wheaton Graduate School and in 2004 his Ph.D. in Theological Education from Trinity Evangelical Divinity School.
"Several years ago, I enjoyed success with Kevin Wilson, while serving together on the Board at Sound Technologies, a digital imaging firm Kevin founded and successfully sold," said Dr. Sveen. "Today, I am excited to be reunited in another opportunity with Kevin and others from that winning team as they join the many talented people at Heska. I look forward to working with them as we form a culture of execution in this new and exciting chapter at Heska."
"We are pleased to add someone with Dr. Sveen's experience and judgment to our Board," commented Robert Grieve, Heska's Chairman and Chief Executive Officer. "We are convinced Dr. Sveen will help us on our mission of improving our business and creating shareholder value."
Heska Corporation (NASDAQ: HSKA - News) sells advanced veterinary diagnostic and other specialty veterinary products. Heska's state-of-the-art offerings to its customers include diagnostic instruments and supplies as well as single use, point-of-care tests, pharmaceuticals and vaccines. The Company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians. For further information on Heska and its products, visit the company's website at www.heska.com.
This announcement contains forward-looking statements regarding Heska's future financial and operating results. These statements are based on current expectations and are subject to a number of risks and uncertainties. There are uncertainties regarding the ability of any Board member, or the Board of Directors as a group, to impact Heska's operating and financial performance; uncertainties related to relying on past performance to predict future success; risks relating to any individual's judgment as to how another individual, or group of individuals, will perform in the future; uncertainties related to Heska's ability to retain its current Board members; risks related to Heska's ability to sell and market its products in an economically sustainable manner; and the risks set forth in Heska's filings and future filings with the Securities and Exchange Commission, including those set forth in Heska's Quarterly Report on Form 10-Q for the quarter ended September 30, 2013.
SOURCE Heska Corporation